Breckenridge pharmaceuticals duloxetine recall
Definition
A voluntary pharmaceutical Class II recall initiated by Breckenridge Pharmaceutical, Inc. in April 2026, involving specific lots of generic duloxetine delayed-release capsules (30mg and 60mg).
A significant product safety action prompted by the presence of an N-nitroso-duloxetine chemical impurity exceeding FDA-approved safety thresholds, alongside reports of Current Good Manufacturing Practice (CGMP) deviations.
Examples
I was looking for a mood boost, but my bottle of duloxetine decided to provide an extra shot of toxic impurities instead thanks to the Breckenridge recall.
If you follow the Breckenridge pharmaceuticals duloxetine recall instructions, you might find your medicine cabinet is now strictly for display purposes only.
The Breckenridge pharmaceuticals duloxetine recall is surely the most exciting thing to happen to generic antidepressant packaging since the invention of the child-proof cap.